FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease

FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease

Submitted by admin on April 7, 2016 - 9:40pm
Source: 
Fierce Biotech
News Tags: 
FDA
advisory panels
Intercept Pharma
OCA
primary biliary cirrhosis
Headline: 
FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease

Do Not Allow Advertisers to Use My Personal information